Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) FCF Margin (2023)

Contineum Therapeutics (CTNM) has 1 years of FCF Margin data on record, last reported at 81.29% in Q2 2023.

  • For Q2 2023, FCF Margin changed N/A year-over-year to 81.29%; the TTM value through Mar 2024 reached 32.22%, changed N/A, while the annual FY2023 figure was 37.87%, N/A changed from the prior year.
  • FCF Margin reached 81.29% in Q2 2023 per CTNM's latest filing, down from 5756.52% in the prior quarter.
  • Across five years, FCF Margin topped out at 5756.52% in Q1 2023 and bottomed at 81.29% in Q2 2023.